Indie Game Schedule I Faces Copyright Dispute, Sparks Fan Backlash

Schedule I faces copyright infringement claims, but fans are review-bombing the accuser’s games in response. Learn more about the dispute and Schedule I’s latest updates.

Schedule I Latest Developments

Schedule I’s Accuser Hit with Steam Review Backlash

Indie crime simulation game Schedule I has been accused of copyright infringement by Movie Games S.A., developers of the Drug Dealer Simulator series. According to a Polish Press Agency report on April 3, Movie Games S.A. completed a legal review, alleging that Schedule I copied elements of their game’s storyline, mechanics, and user interface.

While the investigation remains unresolved, fans have taken sides, with Schedule I gaining significant support. On Steam, Drug Dealer Simulator and Drug Dealer Simulator 2 have faced a wave of negative reviews, now rated “Overwhelmingly Negative” and “Mostly Negative,” respectively.

Recent reviews criticize Movie Games S.A. for targeting an indie developer while ignoring similar games in the past. This backlash overshadows the Drug Dealer Simulator series’ reputation as a top criminal management game, praised by fans and critics alike.

Schedule I, a co-op crime simulation where players rise from small-time dealers to kingpins, launched in Early Access on PC on March 25. It has earned “Overwhelmingly Positive” Steam reviews and ranks as Steam’s second top-selling game, surpassing titles like inZOI, Monster Hunter Wilds, and indie game R.E.P.O. SteamDB reports a peak of 459,075 concurrent players for Schedule I.

At Game8, we found Schedule I’s Early Access release highly engaging, akin to a “Breaking Bad” simulator. Read our full review for more insights!